Suggestions
Stefan Wohlfeil
Chief Medical Officer at Quercis Pharma AG
Professional Background
Stefan Wohlfeil is a seasoned expert in the pharmaceutical and healthcare sectors, holding an impressive array of leadership roles that showcase his extensive experience and commitment to improving patient outcomes. As the Chief Medic at Quercis Pharma AG, he is at the forefront of innovative therapeutic developments, where his expertise in medicine and research is pivotal in guiding the company toward advancing healthcare solutions that make a real difference.
Stefan has a robust career trajectory marked by significant positions within renowned organizations, including Vifor Pharma, where he served as the Chief Medical Officer and Head of R&D, further extending his influence as Senior Vice President. During his tenure at Vifor Pharma, he was integral in spearheading research and development initiatives that resulted in significant therapeutic advancements in the treatment of iron deficiency and related disorders. His leadership was instrumental in navigating complex clinical trials and fostering a culture of scientific excellence.
Prior to this, he held the role of Vice President, Head of Chemical and Preclinical R&D at Vifor Pharma, where he laid the groundwork for groundbreaking preclinical studies that later enhanced patient care. His extensive historical experience encompasses roles such as Global Head of Clinical Research and Biostatistics at Novartis Consumer Health, where he focused on developing robust clinical trials frameworks and leveraging data to inform pharmaceutical development.
In addition, Stefan has made significant contributions as a CEO at notable companies, including TRIN Pharma and Atani Limited. His leadership approach not only increased operational efficiencies but also fostered collaborative environments where innovation flourished. His journey also includes impactful contributions at Bayer, serving in multiple functions including Global Project Leader, Vice President Global Clinical Pharmacology, and Senior Vice President Research, allowing him to leverage cross-functional expertise in managing complex research portfolios.
Education and Achievements
Stefan Wohlfeil's educational foundation was established at the University of Düsseldorf, where he honed his medical knowledge and research acumen, preparing him for a successful career in the pharmaceutical industry. His academic background laid the groundwork for a deep understanding of both medicine and the intricacies of drug development processes. His innovations and contributions have earned him recognitions within the medical and scientific communities, showcasing his commitment to excellence and passion for improving health outcomes worldwide.
Stefan's professional accomplishments outline a trajectory of relentless pursuit of knowledge and excellence, culminating in numerous successful product launches and research breakthroughs throughout his career. He has continually demonstrated an ability to combine rigorous scientific inquiry with practical implementation, a skill that has served him and the organizations he has worked with exceptionally well.
Achievements
Throughout his extensive career, Stefan Wohlfeil has amassed a wealth of achievements, including:
- Chief Medic at Quercis Pharma AG: Leading the development of novel therapeutics aimed at addressing unmet medical needs.
- Vice President at Vifor Pharma: Oversaw critical R&D projects, driving forward innovative solutions in iron deficiencies.
- Leadership Roles at Bayer: Contributed to groundbreaking research that advanced Bayer’s pharmacological reach in various therapeutic areas.
- CEO Positions: Successfully managed both TRIN Pharma and Atani Limited, both pivotal in clinical advancements and therapeutic innovations.
Stefan's broad history across diverse pharmaceutical organizations underlines a career dedicated to improving healthcare outcomes, demonstrating that effective leadership in research and development requires both vision and adaptability.
